Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3043% below fair value
$80.79−4.78 (-5.59%)
Close on Nov 19, 2026Market cap $33.38BP/E 13.3Yield 2.51%
Zoetis net income
Net income is the profit left for shareholders after every expense, interest and tax.
Zoetis's net income for the twelve months ending Jun 30, 2026 was $2.62B, up 1.0% year over year. For fiscal 2025 it was $2.67B, up 7.5% from the year before. Over ten years it grew 22.9% a year on average. The highest annual figure on record is $2.67B in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.67B | +7.5% |
| FY2024 | Dec 31, 2024 | $2.49B | +6.1% |
| FY2023 | Dec 31, 2023 | $2.34B | +10.9% |
| FY2022 | Dec 31, 2022 | $2.11B | +3.8% |
| FY2021 | Dec 31, 2021 | $2.04B | +24.4% |
| FY2020 | Dec 31, 2020 | $1.64B | +9.2% |
| FY2019 | Dec 31, 2019 | $1.50B | +5.0% |
| FY2018 | Dec 31, 2018 | $1.43B | +65.3% |
| FY2017 | Dec 31, 2017 | $864.00M | +5.2% |
| FY2016 | Dec 31, 2016 | $821.00M | +142.2% |
| FY2015 | Dec 31, 2015 | $339.00M | -41.9% |
| FY2014 | Dec 31, 2014 | $583.00M | +15.7% |
| FY2013 | Dec 31, 2013 | $504.00M | +15.6% |
| FY2012 | Dec 31, 2012 | $436.00M | +78.0% |
| FY2011 | Dec 31, 2011 | $245.00M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $691.00M | -4.8% |
| Q1 FY2026 | Mar 31, 2026 | $601.00M | -0.2% |
| Q4 FY2025 | Dec 31, 2025 | $603.00M | +3.8% |
| Q3 FY2025 | Sep 30, 2025 | $721.00M | +5.7% |
| Q2 FY2025 | Jun 30, 2025 | $726.00M | +16.3% |
| Q1 FY2025 | Mar 31, 2025 | $602.00M | +0.5% |
| Q4 FY2024 | Dec 31, 2024 | $581.00M | +10.7% |
| Q3 FY2024 | Sep 30, 2024 | $682.00M | +14.4% |
| Q2 FY2024 | Jun 30, 2024 | $624.00M | -7.0% |
| Q1 FY2024 | Mar 31, 2024 | $599.00M | +8.5% |
| Q4 FY2023 | Dec 31, 2023 | $525.00M | +13.9% |
| Q3 FY2023 | Sep 30, 2023 | $596.00M | +12.7% |
| Q2 FY2023 | Jun 30, 2023 | $671.00M | +26.8% |
| Q1 FY2023 | Mar 31, 2023 | $552.00M | -7.2% |
| Q4 FY2022 | Dec 31, 2022 | $461.00M | +11.4% |
| Q3 FY2022 | Sep 30, 2022 | $529.00M | -4.2% |
| Q2 FY2022 | Jun 30, 2022 | $529.00M | +3.3% |
| Q1 FY2022 | Mar 31, 2022 | $595.00M | +6.4% |
| Q4 FY2021 | Dec 31, 2021 | $414.00M | +15.3% |
| Q3 FY2021 | Sep 30, 2021 | $552.00M | +15.2% |
| Q2 FY2021 | Jun 30, 2021 | $512.00M | +35.8% |
| Q1 FY2021 | Mar 31, 2021 | $559.00M | +32.2% |
| Q4 FY2020 | Dec 31, 2020 | $359.00M | -6.5% |
| Q3 FY2020 | Sep 30, 2020 | $479.00M | +10.6% |
| Q2 FY2020 | Jun 30, 2020 | $377.00M | +1.6% |
| Q1 FY2020 | Mar 31, 2020 | $423.00M | +35.6% |
| Q4 FY2019 | Dec 31, 2019 | $384.00M | +11.3% |
| Q3 FY2019 | Sep 30, 2019 | $433.00M | +24.8% |
| Q2 FY2019 | Jun 30, 2019 | $371.00M | -3.4% |
| Q1 FY2019 | Mar 31, 2019 | $312.00M | -11.4% |
| Q4 FY2018 | Dec 31, 2018 | $345.00M | +325.9% |
| Q3 FY2018 | Sep 30, 2018 | $347.00M | +16.4% |
| Q2 FY2018 | Jun 30, 2018 | $384.00M | +55.5% |
| Q1 FY2018 | Mar 31, 2018 | $352.00M | +47.9% |
| Q4 FY2017 | Dec 31, 2017 | $81.00M | -47.4% |
| Q3 FY2017 | Oct 1, 2017 | $298.00M | +24.7% |
| Q2 FY2017 | Jul 2, 2017 | $247.00M | – |
| Q1 FY2017 | Apr 2, 2017 | $238.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $154.00M | – |
| Q3 FY2016 | Oct 2, 2016 | $239.00M | – |
See a number that looks wrong?